Virtus Logo


Accelerating respiratory clinical research
World leaders specialising in human challenge trials, Virtus provide a bespoke academic
approach to the design, supervision and analysis of respiratory clinical trials
Please note our last antibody test run will be on the 6th of December

Human Studies

Learn more

Virtus’s range of in vitro and in vivo pre-clinical models

Learn more

Meet the Virtus team

Learn more

Virtus team publication track record

Learn more

Virtus can assist in the development of new treatments for asthma and COPD

Learn more

COVID-19 Antibody testing

Learn more
Got any questions? Email or call us on 0207 554 5855


We are delighted to announce the launch of the first publicly available Covid-19 antibody test specifically for the Omicron variant.


Get in touch

Want to find out more how we can help you develop the next block-buster medicine in asthma or COPD? Get in touch.

Our clients

We partner with a range of clients from large pharmaceutical companies to biotechs to assist them in the development of new medicines for respiratory diseases.

Keep Updated With Our Progress

Keep up with the latest results, news and other headlines from Virtus Respiratory Research.

The email address is incorrect
Please agree to our Privacy and Policy
Something went wrong